オプションチェーンは、Bolt Projects Holdingsの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Bolt Projects Holdingsの市場センチメントを評価します。.

Bolt Projects Holdings (NASDAQ:BSLK) 株価情報, オプションチェーン

Bolt Projects Holdings

Bolt Projects Holdings Inc develops and produces biomaterials products. Its flagship products from its Vegan Silk Technology Platform, b-silk and xl-silk, are a biodegradable and vegan protein polymer and a replacement for silicone elastomers in beauty and personal care.

Bolt Projects Holdings, Inc. - Common Stock

Bolt Projects Holdings Inc

News

Trucordia Announced It Will Receive A $1.3B Strategic Investment From Global Investment Firm Carlyle's Global Credit Platform

<a href="https://api.newsfilecorp.com/redirect/QOevbfBjjk">BioHarvest Sciences Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHST#NASDAQ">BHST</a>) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced the launch of VINIA&#xAE; DailyChews 2X Formula, a first-of-its-kind chew designed to increase nitric oxide production and arterial dilation, and to enhance blood flow and oxygen delivery for athletes and individuals with highly active lifestyles. VINIA&#xAE; DailyChews 2X Formula are now available for purchase in a 30-count pack on <a href="https://api.newsfilecorp.com/redirect/m3rNmcmvz7">VINIA.com</a>.
Formulated with a double dose of BioHarvest's proprietary red grape cell composition, VINIA&#xAE; DailyChews 2X Formula are officially Informed Sport-certified, underscoring the Company's commitment to cleaner, safer, and effective performance nutrition. The globally recognized certification ensures every batch is tested for banned substances, making it a trusted choice for professional athletes, military personnel, and fitness enthusiasts alike.
Each individually packaged VINIA&#xAE; DailyChews 2X Formula contains 800mg of VINIA&#xAE; and 12 mg of Piceid resveratrol, which has been clinically shown to increase arterial dilation. This arterial dilation improves blood flow, delivering more oxygen and nutrients to the body's muscles, tissues, and cells, improving physical energy and mental alertness.

BHST

BioHarvest Sciences Launches VINIA DailyChews 2X Formula, For Athletes And Individuals With Highly Active Lifestyles

American Express Canada, The Official Payments Partner Of Formula 1 Is Launching Maison Amex, A Bespoke Pit Stop For Select Cardmembers During The Formula 1 Pirelli Grand Prix Du Canada 2025 Race Weekend

Today, CIBC announced the launch of a new dedicated <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4441780-1&amp;h=1050257808&amp;u=https%3A%2F%2Fcibc.com%2Fbusinessskilledtrades&amp;a=Business+Banking+program">Business Banking program</a>&nbsp;tailored for skilled trades professionals. This initiative builds on the success of CIBC's first-of-its-kind skilled trades <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4441780-1&amp;h=571380162&amp;u=https%3A%2F%2Fwww.cibc.com%2Fen%2Fpersonal-banking%2Fbank-accounts%2Fskilled-trades.html&amp;a=Personal+Banking+program">Personal Banking program</a> introduced last June. Together, these initiatives are designed to enhance support for a sector that is crucial to the Canadian economy.

CIBC Launches Business Banking Program to Support Skilled Trades Pros Across Canada

MAIN

Main Street Capital Announced That It Recently Completed A New Portfolio Investment To Facilitate The Minority Recapitalization Of A Leading Aerial Survey Platform, With Main Street Funding $45.4M In A Combination Of First Lien, Senior Secured Term Debt And A Direct Equity Investment

GUTS

Fractyl, Bariendo Ink LOI To Develop Scalable Clinical Pathway For Revita In Metabolic Endoscopy Centers Nationwide

SION-719 and SION-451 were generally well tolerated and achieved desired pharmacokinetic targets that reinforce their potential as either an add-on to standard of care or in a Sionna dual combination
Sionna plans to advance SION-719 to a Phase 2a proof-of-concept add-on to standard of care trial in cystic fibrosis patients, and SION-451 to a Phase 1 healthy volunteer dual combination trial
Next trials to initiate in the second half of 2025 with topline data expected in mid-2026
Sionna to hold a conference call today at 8:00 a.m. ET
WALTHAM, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SION#NASDAQ">SION</a>), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, today announced positive data from its Phase 1 clinical trials of SION-719 and SION-451, the company's first-in-class nucleotide-binding domain 1 (NBD1) stabilizers, in healthy volunteers. Both NBD1 stabilizers were generally well tolerated and achieved pharmacokinetic (PK) concentration targets established using Sionna's preclinical CF human bronchial epithelial (CFHBE) model. These data reinforce the potential of both NBD1 stabilizers to provide clinically meaningful benefit for CF patients, including the potential for wild-type CFTR function, either as an add-on to standard of care (SOC), or in a proprietary dual combination with complementary modulators. Sionna plans to advance both NBD1 stabilizers to the next stage of clinical development — SION-719 to a Phase 2a proof-of-concept (POC) trial in CF patients as an add-on to SOC, and SION-451 to a Phase 1 proprietary dual combination trial in healthy volunteers.

SION

Sionna Therapeutics Reports Data From Phase 1 Clinical Trials Of SION-719 And SION-451, First-In-Class NBD1 Stabilizers, In Healthy Volunteers

New Era Helium, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEHC#NASDAQ">NEHC</a>) ("NEHC" or the "Company"), a next-gen exploration and production platform in the Permian Basin, today announced that the Texas Critical Data Centers, LLC ("TCDC") joint venture has entered into a non-binding Memorandum of Understanding ("MOU") with PowerForward Energy Solutions ("PFES") to provide 250MW of on-site generation capacity to power its planned AI and high-performance computing ("HPC") campus in Ector County, Texas.
TCDC, the joint venture established between New Era Helium and Sharon AI, Inc. in 2024, is focused on building a 250MW data center to support the rapidly growing demand for AI and cloud GPU infrastructure. Under the terms of the MOU, signed on April 23, 2025, PFES has agreed to manufacture, install, and operate 250MW of generation assets at the TCDC site, with the first 100MW targeted for delivery within 12 months of funding and full deployment expected within 18 months.
PFES is a joint venture between Progen Industries, a U.S.-based manufacturer of natural gas-fired engine-driven generators, and MBS Engineering, Inc. The partners bring more than 70 years of combined experience in delivering resilient, distributed power solutions for critical infrastructure.
Work at the site continues to progress, including the completion of the Phase I Environmental Site Assessment and ongoing planning for air permitting. NEHC, Sharon AI, and PFES are also jointly evaluating carbon capture technologies. TCDC is in active discussions with potential customers, including parties interested in acquiring powered land for near-term deployment. Near-term milestones include securing natural gas supply agreements and advancing interconnection planning with regional grid partners.

NEHC

New Era Helium JV to Power Texas AI Data Center with 250MW from On-Site Generators

JBLU

JetBlue Announced The Official Launch Of Paisly, Llc, Formerly Jetblue Travel Products

<a href="https://www.veeva.com/">Veeva Systems</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) and Sarah Cannon Research Institute (SCRI) today announced a strategic collaboration to drive speed and efficiency in oncology clinical trials across SCRI's more than 200 research site locations. SCRI is adopting <a href="https://www.veeva.com/products/veeva-clinical-platform/">Veeva Clinical Platform</a> to unify its contract research organization (CRO) and site management organization (SMO) on a single platform for seamless data flow across clinical teams and research sites.

VEEV

Veeva Teams Up with Sarah Cannon to Speed Up Cancer Trials at 200+ Research Sites

Cohort 3 demonstrates earlier and deeper responses compared to cohorts 1-2
All three cohorts show separation from placebo with statistically significant difference from placebo at day 28
Cohort 3 demonstrates clinically meaningful reduction in itch as early as day 8
Enrollment initiated in extension cohort study exploring the same cohort 3 dose (200 mg BID) for a longer 8-week treatment period
SOUTH SAN FRANCISCO, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRVS#NASDAQ">CRVS</a>), a clinical-stage biopharmaceutical company, today announced new interim data from the randomized, double-blind, placebo-controlled Phase 1 clinical trial evaluating soquelitinib in patients with moderate to severe atopic dermatitis. The data includes 28-day follow up results for all patients in cohort 3 and continues to show earlier and deeper responses in cohort 3 (200 mg twice per day, total daily dose 400 mg) compared to cohorts 1 and 2 (100 mg twice per day and 200 mg once per day, total daily dose 200 mg). Overall, data from cohorts 1-3 of the trial have demonstrated a favorable safety and efficacy profile, including a statistically significant improvement in Eczema Area and Severity Index (EASI) score for the soquelitinib treated patients compared to placebo at day 28 (p=0.036).

CRVS

Corvus Pharma Announces New Interim Data From Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial Evaluating Soquelitinib In Patients With Moderate To Severe Atopic Dermatitis

<a href="https://www.veeva.com/">Veeva Systems</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) today announced Astellas has chosen <a href="https://www.veeva.com/products/crm-suite/crm/">Veeva Vault CRM</a>&nbsp;globally and <a href="https://www.veeva.com/cn/veeva-china-crm-suite-en/">Veeva China CRM</a> for China.
&nbsp;
"At Astellas, we discover and deliver transformative therapies for patients around the world," said Nick Eshkenazi, chief digital and transformation officer at Astellas. "Having a foundation for commercial agility and execution is crucial. Our collaboration with Veeva will provide us with technology solutions and data to enhance our agility as a company while we partner with an entity that shares our values and focus on patients."
"Astellas is a leader in improving the health of people around the world through their innovative science and healthcare solutions," said Matt Farrell, president, commercial strategy at Veeva. "With Vault CRM, we are excited to deepen our partnership to support Astellas in that mission."
Vault CRM addresses the industry's unique and evolving country-specific business needs and compliance requirements. It is part of the Vault CRM Suite that connects sales, marketing, and medical teams for seamless collaboration and more effective commercial execution.

Astellas Picks Veeva's Vault CRM to Boost Global Sales and Marketing Agility

On June 4, 2025, New Century Logistics (BVI) Limited (hereinafter referred to as "New Century") has entered into a Letter of Intent (hereinafter referred to as "LOI") with Ms. Chiu Nga Ting, the sole shareholder of Asiatic Logistics Limited ( hereinafter referred to as "Asiatic"), to acquire 51% of the issued and outstanding shares of Asiatic. This strategic move is aimed at enhancing New Century's presence in Asia and advancing the development of a comprehensive global logistics ecosystem. The signing of the LOI signifies a significant milestone in the ongoing strategic partnership between New Century and Asiatic. It builds upon the existing framework agreement and underscores the mutual commitment to leveraging synergies and optimizing operational efficiencies. This acquisition is expected to bolster New Century's core advantages in the Asian market and catalyze the full-chain upgrade of its global logistics network.
Strategic upgrade: from framework cooperation to equity binding, build a deep collaborative ecology
New Century and Asiatic have a long-standing history of collaboration. In July 2023, the two parties entered into a Strategic Cooperation Framework Agreement, focusing on complementary transportation services, joint market expansion, and resource sharing. The goal of this partnership was to build an integrated "global-regional" logistics network. The proposed acquisition of 51% equity in Asiatic represents a strategic upgrade based on the successful outcomes of previous cooperation. This move aims to deepen the mechanism of shared benefits through equity binding, promoting a leapfrog development from business collaboration to strategic win-win outcomes.
Asiatic, as a benchmark company in the logistics sector of East Asia, has been deeply involved in the air freight markets of Japan and Southeast Asia since its establishment in 2007. Asia has leveraged its core services, such as "Japan Dedicated Line," "General Cargo Charter Flights," and "Special Cargo Transportation," along with the support of its subsidiary, JP International Logistics Limited (which focuses on Japanese e-commerce business), to become one of the most competitive logistics service providers in East Asia. Its main businesses, including "Hong Kong to Japan Charter Flights for E-commerce" and "Air Freight Capacity in Europe/Western Asia/Southeast Asia," complement the cross-continental air freight advantages of New Century in the United States, Europe, and the Middle East.
Core of acquisition: strengthen the Asian hub and improve the global network loop
Pursuant to the LOI, the specifics of the proposed 51% equity transaction, including the purchase price and payment terms, will be finalized through a subsequent formal acquisition agreement. This agreement will take into account various factors, such as Asiatic's financial performance, the prevailing market environment and relevant industry benchmarks.
The strategic value of the acquisition to New Century is evident in the following three key areas:
<ol>
<li>Deep cultivation in the Asian market: Asiatic's extensive local network, customs clearance experience, and e-commerce freight advantages in Japan and Southeast Asia will significantly bolster New Century's "last mile" service offerings in Asia. This is particularly crucial given the rapid growth of cross-border e-commerce, enabling New Century to solidify its position as a leading logistics hub in East Asia. &nbsp;</li>
<li>Global Link Network Expansion: By integrating Asiatic's operations with New Century's existing routes in the United States, Europe, and the Middle East, the acquisition will create a seamless "Asia-Europe-Middle East" logistics corridor. This will allow New Century to offer customers an integrated "door-to-door" cross-border transportation solution, enhancing its global logistics capabilities.</li>
<li>Resource collaboration and efficiency: The two parties will collaborate further by sharing warehousing facilities, transportation vehicles, and supply chain management systems. This synergy will optimize transportation times and costs while improving market penetration through customer referral mechanisms.</li>
</ol>
Future plan: with Japan as the core, expand the new map of Asian business
Upon the successful completion of the acquisition, New Century will designate Japan as one of its key strategic hubs in Asia, leveraging it to expand both regional and transcontinental business operations. The following initiatives outline New Century's strategic roadmap:
<ul>
<li>Strengthen the function of Japan hub: Utilizing Asiatic's "special line charter," "e-commerce" services, and the expertise of its subsidiary, JP International, Japan will be developed into a "transshipment center" for New Century's Asia region. This hub will connect Southeast Asia, Europe, America, and the Middle East markets, creating a multi-directional logistics channel that links "Japan-Southeast Asia-global; &nbsp;</li>
<li>Develop customized e-commerce logistics products: In response to the explosive growth of the Japanese cross-border e-commerce market, New Century will collaborate with Asiatic to launch a "Japan-global" e-commerce special line service. This service will cover the entire process of forward transportation, customs clearance, warehousing, and terminal distribution, offering e-commerce customers an expedited "72-hour customs clearance + 48-hour door-to-door" express logistics experience. &nbsp;</li>
<li>Deepening local resource integration: Leveraging the Asiatic team's in-depth understanding of the Japanese market, New Century plans to establish strategic partnerships with leading e-commerce platforms and manufacturing enterprises in Japan. This initiative aims to expand the customer base and enhance market penetration. &nbsp;</li>
<li>Driving digital and intelligent upgrades: New Century will integrate its self-developed "Global Supply Chain Visualization System" with Asiatic's existing management platform. This integration will enable real-time synchronization of Japanese warehousing, transportation, and customs clearance data. The enhanced system will improve the accuracy of cargo tracking and the efficiency of abnormal response, providing customers with "one-click query and whole-process control" digital services.</li>
</ul>
Integrity as the foundation, future outlook
The chairman of the New Century board stated: " Asiatic is a 'hidden champion' in the East Asian logistics markets, with deep roots in Japan and Southeast Asia. This acquisition is a perfect fit with our global network, extending our business reach and upgrading our strategic ecosystem. We will use Asia as our bridgehead to drive global logistics services toward greater efficiency and closer alignment with customer needs. Our commitment to integrity and future outlook will guide us as we build a stronger, more integrated global logistics platform."
Ms. Chiu Nga Ting, shareholder of Asiatic, pointed out: " As a NASDAQ-listed company, New Century's international resource integration capabilities and capital strength are key drivers for Asiatic's advancement into cross-continental logistics. We believe that through equity cooperation, both parties will achieve a synergistic effect where '1+1&gt;2', creating greater value for our customers. This partnership is not just about growth; it's about building a future where logistics is seamless, efficient, and customer-centric."

NCEW

New Century Logistics Enters Into LOI With Chiu Nga Ting, Sole Shareholder Of Asiatic Logistics, To Acquire 51% Of Issued And Outstanding Shares Of Asiatic

Needham analyst Joseph Stringer maintains Cidara Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDTX#NASDAQ">CDTX</a>) with a Buy and raises the price target from $35 to $36.

Price Target

Analyst Ratings

CDTX

Needham Maintains Buy on Cidara Therapeutics, Raises Price Target to $36

<ul>
<li>Further details will be provided in an official letter from FDA within 30 days and the company plans to address their questions, once received.</li>
<li>IND Application Submitted to Expand RESTORE-FA Trial to U.S. Sites; Notice Received from&nbsp;FDA&nbsp;Placing&nbsp;Clinical Hold&nbsp;on IND Application to Open U.S. Sites</li>
</ul>

Biotech

Health Care

General

DSGN

Design Therapeutics Submitted An Investigational New Drug Application For DT-216P2 With The FDA, The Company Received A Clinical Hold Notice On The IND Application From FDA Noting Nonclinical Deficiencies

A Southwest Airlines Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>) flight on its way to Tampa, Florida, had to be diverted to South Carolina after a passenger's portable battery pack started smoking.
What Happened: An hour into its journey, flight 1844 from Baltimore to Tampa was diverted to Myrtle Beach following the incident, Business Insider reported <a href="https://www.businessinsider.com/southwest-flight-diverted-day-after-new-rules-for-portable-chargers-2025-6">on</a> Monday.
"A customer&#8217;s battery charger apparently overheated and began to smoke. We appreciate the professionalism of our flight crew in swiftly handling the situation," a spokesperson for the airline cited in the report said. They added that the airline is investigating the incident.
Why It Matters: The news comes in days after the airline introduced an <a href="https://www.benzinga.com/25/05/45541427/southwest-airlines-announces-passengers-must-keep-portable-chargers-in-plain-sight-amid-fears-of-lithium-battery-fires">industry-first policy </a>that required passengers to keep all portable chargers and battery packs in line of sight while in use to prevent any fire incidents.
Earlier this year, passengers in an Air Busan flight were evacuated after a portable charger in an overhead bin caught fire.
The company also ended its decades-old ‘Two Bags Fly Free' policy recently, which will reportedly help the airline generate <a href="https://www.benzinga.com/markets/25/05/45639000/southwest-airlines-to-reap-430-million-in-profit-from-new-baggage-fees-says-analyst">$430 million in profits</a>, according to analysts.
Elsewhere, the company also announced its first trans-Pacific partnership after it <a href="https://www.benzinga.com/news/travel/25/06/45719330/southwest-airlines-makes-first-trans-pacific-move-with-china-airlines-partnership">signed an agreement</a> with Taiwan's China Airlines Group. The agreement would take effect in 2026.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="201" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04062659/LUV-JUN-4-2O25-1024x201.jpg" alt="" class="wp-image-937994" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04062659/LUV-JUN-4-2O25-1024x201.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04062659/LUV-JUN-4-2O25-300x59.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04062659/LUV-JUN-4-2O25-768x151.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04062659/LUV-JUN-4-2O25-1536x301.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04062659/LUV-JUN-4-2O25.jpg 1556w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
LUV scores well on Momentum, Growth and Value metrics. For more such insights, sign up for<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"> Benzinga Edge</a> today!
Check out more of Benzinga's Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/travel/25/05/45692905/faa-extends-program-allowing-boeing-to-conduct-inspections-on-agencys-behalf">FAA Extends Program Allowing Boeing To Conduct Inspections On Agency&#8217;s Behalf</a></li>
</ul>
Image via Shutterstock

Southwest's New Battery Policy In Spotlight After A Smoking Battery Charger Diverts Flight

Telsey Advisory Group analyst Joseph Feldman maintains Dollar General (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) with a Market Perform and raises the price target from $100 to $120.

Telsey Advisory Group Maintains Market Perform on Dollar General, Raises Price Target to $120

Chart Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GTLS#NYSE">GTLS</a>) and Flowserve Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLS#NYSE">FLS</a>) today announced that they have entered into a definitive agreement to combine in an all-stock merger of equals, creating a differentiated leader in industrial process technologies. The combined company is expected to have an enterprise value of approximately $19 billion based on the exchange ratio and the closing share prices for Chart and Flowserve as of June 3, 2025. Additional information can be found at <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.chartflowserve.com%2F&amp;esheet=54264939&amp;newsitemid=20250604874670&amp;lan=en-US&amp;anchor=ChartFlowserve.com&amp;index=1&amp;md5=ec4cd89bd1bbad90d0d8988c45bed8aa">ChartFlowserve.com</a>, a new joint website dedicated to the merger.
This press release features multimedia. View the full release here: <a href="https://www.businesswire.com/news/home/20250604874670/en/">https://www.businesswire.com/news/home/20250604874670/en/</a>
With an installed base of more than 5.5 million assets in more than 50 countries, the combined company will address the full customer lifecycle from process design through aftermarket support. The combined company generated net revenue of approximately $8.8 billion on a combined LTM basis as of the end of Q1 2025, drawn from diverse, high-growth, attractive end markets, including approximately $3.7 billion1 in aftermarket services revenue, representing approximately 42% of combined revenue.
Under the agreement, which has been unanimously approved by the board of directors of each company, at the closing of the transaction Chart shareholders will receive 3.165 shares of Flowserve common stock for each share of Chart common stock owned. Following the close of the transaction, Chart shareholders will own approximately 53.5% and Flowserve shareholders will own approximately 46.5% of the combined company, on a fully diluted basis.
"Combining Chart and Flowserve creates a comprehensive solutions platform, with the financial strength and resilience to continue driving growth and long-term value," said Jill Evanko, President and CEO of Chart. "Together we will provide a complete system of capabilities from front-end engineering design to mission critical equipment through aftermarket and servicing, delivering high-quality, value-added solutions to an expanded, global customer base. With robust cash flow, meaningful synergies, and greater aftermarket growth opportunities, the combined company will be ideally positioned to deliver superior and lasting value to its shareholders."
"The merger will create a differentiated leader with the scale and resilience to meet the significant demand for comprehensive industrial process technologies and services," said Scott Rowe, President and CEO of Flowserve. "Chart's and Flowserve's highly complementary businesses will strengthen our ability to meet our customers' needs, empower innovation and drive long-term, sustainable growth. The combined company will operate across diversified end markets with further exposure to premium, high-growth areas and a substantial aftermarket franchise – resulting in increased commercial opportunities. I am confident that together, we will capitalize on long-term value creation for our customers, partners, shareholders and combined global team."
Strategic and Financial Benefits
<ul>
<li>Comprehensive suite of world-class, differentiated solutions. The combination brings together Chart's leading expertise in process technologies across compression, thermal, cryogenic and specialty solutions and Flowserve's leading capabilities in flow management. Combining digital platforms that underpin this full suite of solutions will enable further opportunities to differentiate solutions, offering a comprehensive digital overlay, including monitoring and predictive capabilities.</li>
<li>Diversified and attractive end markets. The combined company will have leading capabilities across General Industrial, Industrial Gases, Data Centers, Space, Transportation, Nutrition, Carbon Capture, Energy, Power Generation, Nuclear, Chemical, Liquid Natural Gas, Water, and Mining and Minerals. The combined company will be more predictable and resilient.</li>
<li>Expanded aftermarket franchise. The combined company will havesignificant recurring revenue streams, with a global installed base of more than 5.5 million assets and 42% of total combined revenue from aftermarket and service. Chart and Flowserve expect to grow the aftermarket businesses by offering enhanced services and solutions to customers through an expanded global installed base and broad geographic reach.</li>
<li>Upside from significant cost and commercial synergies. The combination is expected to generate approximately $300 million of annual cost synergies within three years following the transaction close, primarily from materials and procurement savings, roofline consolidation, organizational efficiencies, and elimination of duplicate public company costs. The companies also expect to deliver commercial revenue synergies over time representing at least an incremental 2% growth on the combined company's revenue.</li>
<li>Committed to investment grade balance sheet with strong cash flow profile. The combination is expected to be meaningfully accretive to the combined company's Adjusted EPS in the first year following closing. The combined company is expected to have a leverage ratio of 2.0x net debt to adjusted EBITDA at close. On a combined basis, Chart and Flowserve generated $1.8 billion of cash flow2,3 over the 12 months ended March 31, 2025. This strong financial profile will support a balanced capital allocation strategy, deleveraging, prioritizing growth investments, and capital returns. The combined company expects to pay a quarterly dividend consistent with Flowserve's historical per share payout levels and expects to generate additional interest expense savings.</li>
</ul>
Upon closing, the combined company's Board will comprise 12 directors, six of whom will be from Chart and six from Flowserve. Ms. Evanko will serve as the Chair of the combined company's Board of Directors, Mr. Rowe will serve as Chief Executive Officer of the combined company, and John Garrison will serve as Lead Independent Director of the combined company's Board.
Following the closing of the transaction, the combined company will have its headquarters in Dallas, TX and expects to maintain a presence in Atlanta and Houston, supported by a global footprint across more than 50 countries. The combined company will assume a new name and brand following close.
The transaction is expected to close in the fourth quarter of 2025, subject to approval of shareholders of both Chart and Flowserve, the receipt of regulatory approvals, and the satisfaction of other customary closing conditions.

GTLS

Chart and Flowserve to Merge in $19B All-Stock Deal, Creating Industrial Tech Powerhouse, Gives Chart Shareholders 53.5% Stake in $8.8B Revenue Giant

The RESTORE-FA trial is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of IV and subcutaneous administration of DT-216P2 in patients with FA. DT-216P2 has been administered in one patient to date with no adverse events reported, including no injection site thrombophlebitis. The trial is currently open for enrollment in Australia. Design anticipates reporting data from the MAD trial, including levels of frataxin (FXN) expression based on 12 weeks of dosing, in 2026.

Design Therapeutics Announced That The First Friedreich Ataxia Patient Has Been Dosed Via Intravenous Infusion In Its RESTORE-FA Open-label Phase 1/2 Multiple-ascending Dose Trial Of Dt-216P2, Initial Data from the Ongoing, Blinded Phase 1 Single-Ascending Dose Trial Demonstrated Favorable Safety and Pharmacokinetics

REV Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REVG#NYSE">REVG</a>) raises FY2025 sales outlook from $2.30 billion-$2.40 billion to $2.35 billion-$2.45 billion vs $2.38 billion estimate.

Guidance

REVG

REV Group Raises FY2025 Sales Guidance from $2.30B-$2.40B to $2.35B-$2.45B vs $2.38B Est

Press Releases

Bolt Threads Announces Closing of Business Combination and Will Begin Trading on Nasdaq Under New Symbol "BSLK"

Bolt Projects Holdings Announces More Brands Choosing b-silk™ to Differentiate Their Product Offerings

Bolt Projects Reports Q3 2024 Financial Results

Bolt Partners with Goddess Maintenance Co. for Groundbreaking Beauty Launch

Bolt Projects Reports Q4 2024 Financial Results

Bolt Projects Holdings Reports Q1 2025 Financial Results

The CHIPS Act and Peraso Inc. (NASDAQ: PRSO): Advancing Semiconductor Innovation and National Security – More Stocks Inside

BLRX

BMGL

BSLK

GAMC

PRSO

SNYR

TIRX

VIVK

AdvanSix

Braskem

Cabot

Core Molding Technologies Inc Common Stock

Core Molding Technologies

CN Energy Group Inc. - Class A Ordinary Shares

CN Energy Group

Gulf Resources

Hawkins

Koppers Holdings

Kronos Worldwide

Loop Industries

Mativ Holdings

Orion

Olin

Origin Materials, Inc. - Class A Common Stock

Origin Materials

PureCycle Technologies, Inc. - Common stock

PureCycle Technologies

Tronox Holdings

Trinseo

Westlake

Westlake Chemical Partners LP Common Units representing limited partner interests

Comments

Bolt Projects Holdings

Bolt Projects Holdings (BSLK) オプション

No option chain data available. Please try again later

ニュース

パートナーシップ

ベンジンガ・グローバル